Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gejyo

Showing results (1-10 of 243) with videos related to

Pageof 25
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 1, 1986
[Chronic renal failure: present and future. Pathophysiology and metabolic abnormalities--uremic toxin, middle and large molecular substances]F Gejyo
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 8, 2000
Beta 2-microglobulin amyloidF Gejyo
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 20, 2001
[Beta 2-microglobulin and dialysis-related amyloidosis]F Gejyo
Ryoikibetsu Shokogun Shirizu|January 1, 1997
[Carpal tunnel syndrome]F Gejyo
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1997
Clinical and pathogenic factors in dialysis-related amyloidosis: current research findingsF Gejyo
Nihon Jinzo Gakkai Shi|March 1, 1978
[Studies on uremic toxins--biochemical analysis of uremic serum (author's transl)]F Gejyo
Ryoikibetsu Shokogun Shirizu|January 1, 1997
[Dialysis related amyloidosis]F Gejyo
Internal Medicine (Tokyo, Japan)|November 24, 1999
Elevation of serum CA19-9 levels in benign diseasesS Ito, F Gejyo
Methods in Enzymology|October 3, 1999
Kinetic analysis of amyloid fibril formationH Naiki, F Gejyo
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Beta 2-microglobulin-related amyloidosis: where do we stand?F Gejyo, M Arakawa
Pageof 25

Showing results (1-10 of 243) with videos related to

Sort By:
Pageof 25
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 1, 1986
[Chronic renal failure: present and future. Pathophysiology and metabolic abnormalities--uremic toxin, middle and large molecular substances]F Gejyo
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 8, 2000
Beta 2-microglobulin amyloidF Gejyo
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 20, 2001
[Beta 2-microglobulin and dialysis-related amyloidosis]F Gejyo
Ryoikibetsu Shokogun Shirizu|January 1, 1997
[Carpal tunnel syndrome]F Gejyo
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1997
Clinical and pathogenic factors in dialysis-related amyloidosis: current research findingsF Gejyo
Nihon Jinzo Gakkai Shi|March 1, 1978
[Studies on uremic toxins--biochemical analysis of uremic serum (author's transl)]F Gejyo
Ryoikibetsu Shokogun Shirizu|January 1, 1997
[Dialysis related amyloidosis]F Gejyo
Internal Medicine (Tokyo, Japan)|November 24, 1999
Elevation of serum CA19-9 levels in benign diseasesS Ito, F Gejyo
Methods in Enzymology|October 3, 1999
Kinetic analysis of amyloid fibril formationH Naiki, F Gejyo
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Beta 2-microglobulin-related amyloidosis: where do we stand?F Gejyo, M Arakawa
Pageof 25